Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Quality Assistance S.A. is an expert for the development of:
- Biologics (monoclonal antibodies, ADCs, proteins)
- New Chemical Entities, oligonucleotides, peptides
- Nanomedicine products
- Cell-Based and Gene Therapy Medicinal Products
The company holds a unique position on the market with:
All its laboratories on one site (Donstiennes, Belgium)
- Bioanalysis (PK/TK/Immuno)
- Elemental Impurities
- Mass Spectrometry
- Molecular Biology
- Protein Characterisation
200 highly qualified professionals
more than 35 years’ expertise at the forefront of analytical sciences.
Our core competencies are:
- Development and validation of analytical methods
- Stability studies
- Batch (release) testing
- Development and validation of bioanalytical methods
- PK/TK studies
- Immunogenicity studies
- Biomarker studies
The Quality Assistance environment is GMP, GLP and GCLP/GCP compliant.
Visit www.quality-assistance.com for more information
GEM FORLAB gives continuity to the experience of ABLE Biosciences as a global provider of scientific technology and services to the Life Science industry. It delivers solutions to companies of all size and shapes.
GEM FORLAB performs its activities by means of three technology areas:
Mass Spectrometry & Proteomics
Cell and Molecular Biology & Immunoassay
ABLE Biosciences is the Test Facility GLP certified for small and large molecules quantitative analysis in biological matrices by means of Mass Spectrometry, Immunometric assays and qPCR and it is included in OsSC register of Private Laboratories qualified to perform analysis on samples derived from drug clinical trials (phase I-II-III) in compliance with GCP.
The Chemistry Unit provides all essential components for early drug discovery such as synthesis of chemical intermediates, process impurities, reference compounds, drug metabolites, and pro-drug; lead generation and optimization; bioconjugate chemistry; targeted molecules for MRI and others Molecular Imaging techniques.
Alpha Laboratories is a family-run laboratory and diagnostic supplies business based in Eastleigh, Hampshire, UK and celebrated its 40th anniversary in 2015.
Since 1975 we have helped scientists to improve the health of the nation by sourcing and supplying specialist products from leading worldwide manufacturers.
In addition the company has developed its own brand lines of essential laboratory consumables such as the high quality Pastette® transfer pipettes, eco friendly Fastrak® pipette tips and SpeciSafe® UN3373 compliant sample packaging.
Our wide range of liquid handling pipettes, sample tubes, microtubes, microplates, PCR and general lab consumables, plus molecular biology equipment, ensure top performance in the laboratory.
Alpha Laboratories supports clinical laboratories with an extensive array of diagnostic assays, reagents and equipment. These cover blood grouping, gastroenterology, clinical chemistry, haematology, haemostasis and immunology testing, plus consumables for sample collection and transport .
We are highly experienced in faecal calprotectin testing to distinguish between IBD and IBS. We also provide Faecal Occult Blood testing materials to Bowel Cancer Screening Programmes nationwide and are involved in the transition to the use of more specific and sensitive Faecal Immunochemical Tests (FIT). Alpha Laboratories is also promoting the use of specialist assays such as new Rapid Pathogen ID technology that could vastly improve the speed of targeted treatment for sepsis.
We are a customer focused company dedicated to providing exceptional service, support and value for money for medical and laboratory professionals.
Explicyte is a family brand of specialty preclinical services launched by ImmuSmol, a bordeaux-based company. The first brand, Explicyte Immune-Oncology offers preclinical contract research services in immuno-oncology.
Explicyte Immuno-Oncology currently offers to test innovative cancer immunotherapies in vivo, using syngeneic mouse tumor models treated with immune checkpoint inhibitors (eg. anti-CTLA-4 and anti-PD1/PD-L1 antibodies). In addition, Explicyte is setting up an in vitro platform for the identification and optimization of novel immunomodulators. Equipped with high-content analysis technologies, the platform focuses on live phenotypic screening in co-cultures of immune and cancer cells, as well as molecular cell-based assays for the assessment of immune checkpoint inhibitors.
Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies.
Fluofarma's contract research services are based on the following capacities:
CUSTOM BIOLOGICAL MODELS
> Generation of primary cell cultures, cell lines, 3D spheroids
> Development of multi-cell type culture systems in 2D & 3D
> Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs)
ADAPTATION & DEVELOPMENT OF CELL-BASED ASSAYS
> 100 phenotypic and molecular assays for immediate performance or adaptation to specific cell types
> Multiplexing, miniaturization, automation of cell-based assays
> Assay development with the cellular model, readout, and high-content screening technology needed
> Design and development of biomarker assays
> Automated biomarker quantification in tissue sections and tissue microarrays (TMAs)
> Biomarker analysis in whole blood by high-throughput flow cytometry
Since 2003, Fluofarma has been supporting over 70 pharmaceutical companies in the dicovery of new therapeutic targets, compounds and biomarkers.
To learn more about Fluofarma’s contract research services, please visit www.fluofarma.com